Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults

NCT06815991 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Metro International Biotech, LLC